OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.
Former DeepMind researcher David Silver has secured $1.1 billion in funding for Ineffable Intelligence, a UK-based AI lab ...
Zacks Investment Research on MSN
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.50, moving -6.17% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.41%. At ...
Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to ...
Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
Backed by a $1M+ commercial license and 1B+ solutions evaluated, Project 777 is moving frontier AI from raw model ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...
As AI systems increasingly control life-and-death decisions—from autonomous vehicles to medical diagnostics to financial markets—a critical vulnerability threatens to undermine their promise: these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results